Trial intelligence / Profile preview

Pregabalin for postoperative sleep after video-assisted thoracoscopic surgery

ChiCTR2300071850Phase 4Not yet recruiting

Sponsor
The Affiliated Hospital of Xuzhou Medical University
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of pregabalin in Postoperative sleep disturbance (PSD) (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of sleep disorder on the night of operation. Planned start Jun 2023; status: not yet recruiting.

02

Drugs

pregabalin
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on ChiCTR2300071850.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300071850.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call